Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (41-50 of 375) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2018
Reply to V. Turan et alMatteo Lambertini, Ann H Partridge, Lucia Del Mastro
ESMO Open|November 16, 2016
Twenty years of anti-HER2 therapy-associated cardiotoxicityNoam F Pondé, Matteo Lambertini, Evandro de Azambuja
Cancer Treatment Reviews|March 22, 2015
Targeted agents for cancer treatment during pregnancyMatteo Lambertini, Fedro A Peccatori, Hatem A Azim
Breast (Edinburgh, Scotland)|March 21, 2018
Reply to the letter "Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association"Elena Poletto, Samuel Martel, Matteo Lambertini, et al.
Expert Opinion on Pharmacotherapy|April 13, 2017
Pharmacotherapy to protect ovarian function and fertility during cancer treatmentMatteo Lambertini, Chiara Dellepiane, Giulia Viglietti, et al.
Obstetrics and Gynecology|September 23, 2015
Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysisMatteo Lambertini, Francesca Poggio, Alessia Levaggi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2020
Reply to S. A. Narod et alHatem A Azim, Lieveke Ameye, Marianne Paesmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast CancerMatteo Lambertini, Eva Blondeaux, Francesco Perrone, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs)Matteo Lambertini, Lucia Del Mastro, Andrea Bellodi, et al.
Oncotarget|March 9, 2019
Oncofertility counselling in premenopausal women with HER2-positive breast cancerMatteo Lambertini, Isabelle Demeestere, Giulia Viglietti, et al.
Pageof 38

Showing results (41-50 of 375) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2018
Reply to V. Turan et alMatteo Lambertini, Ann H Partridge, Lucia Del Mastro
ESMO Open|November 16, 2016
Twenty years of anti-HER2 therapy-associated cardiotoxicityNoam F Pondé, Matteo Lambertini, Evandro de Azambuja
Cancer Treatment Reviews|March 22, 2015
Targeted agents for cancer treatment during pregnancyMatteo Lambertini, Fedro A Peccatori, Hatem A Azim
Breast (Edinburgh, Scotland)|March 21, 2018
Reply to the letter "Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association"Elena Poletto, Samuel Martel, Matteo Lambertini, et al.
Expert Opinion on Pharmacotherapy|April 13, 2017
Pharmacotherapy to protect ovarian function and fertility during cancer treatmentMatteo Lambertini, Chiara Dellepiane, Giulia Viglietti, et al.
Obstetrics and Gynecology|September 23, 2015
Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysisMatteo Lambertini, Francesca Poggio, Alessia Levaggi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2020
Reply to S. A. Narod et alHatem A Azim, Lieveke Ameye, Marianne Paesmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast CancerMatteo Lambertini, Eva Blondeaux, Francesco Perrone, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs)Matteo Lambertini, Lucia Del Mastro, Andrea Bellodi, et al.
Oncotarget|March 9, 2019
Oncofertility counselling in premenopausal women with HER2-positive breast cancerMatteo Lambertini, Isabelle Demeestere, Giulia Viglietti, et al.
Pageof 38